CERN Accelerating science

NEWS!

• 04/2026

The Programme for 2026 has restarted with mass separation of external targets or long-lived CERN sources, with an exciting scientific programme ahead combining proof-of-concept and clinical translation of MEDICIS High Molar Activity grade radionuclides.

• 01/2026

Happy new year from the MEDICIS team and support groups !

• 01/2026

PRISMAP has delivered its last radionuclide last December, the programme coordinated by CERN with MEDICIS mass separation had been a large success, as reported now on CERN website .

• 07/2025

A delegation including IAEA DDG Najat Mokhtar visiting the facility while a first test for Ac-226 theranostic alpha emitter metrology was performed onsite by NPL-Dr Sean Collins.

• 04/2025

The facility has restarted after its shutdown, with an exciting programme ahead - We may witness the 1st use of MEDICIS-separated treatment radionuclides in clinical research in hospitals after the positive decision of the CERN Council.

• 12/2024

CERN hosted (in room Curie !) the 13th MEDICIS collaboration board followed by the 7th Anniversary of the first collected radionuclide!

• 09/2024

CERN hosted the 21st Plenary Meeting of the European Observatory on the the Supply of Medical Radionuclides on 25 and 26 of September 2024.

​​

JOB OPPORTUNITIES

We are looking for a CERN staff position as target materials engineer for MEDICIS and for ISOLDE class A laboratory. Applications are Closed.

e